Biodesix, Inc.
BDSXNASDAQHealthcareDiagnostics & Research
As of Oct 23, 2026 close
- Market cap
- $218.07M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.26$31.97
- Volume (live)
- -
- Avg. volume (3M)
- 95.90K
Biodesix (BDSX) Stock Price & Financial Analysis
Biodesix Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $21.11 - $23.70 |
|---|---|
| 52-Week High | $31.97 |
| 52-Week Low | $5.26 |
| Open | $23.66 |
| Volume (last close) | 139.51K |
| Average Volume (3M) | 95.90K |
| Revenue (TTM) | 102.94M |
|---|---|
| Net Income (TTM) | -27.76M |
| Free Cash Flow (TTM) | -20.34M |
| EPS (TTM) | −$3.13 |
| Profit Margin | -26.97% |
| Operating Margin | -20.00% |
| Return on Equity (ROE) | -303.61% |
| Debt to Equity | 5.30 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 218.07M |
|---|---|
| Shares Outstanding | 10.30M |
| Price to Sales (P/S) | 2.12 |
| Price to Book (P/B) | 23.85 |
| EV/EBITDA | -17.83 |
| 50-Day MA | $26.63 |
|---|---|
| 200-Day MA | $18.03 |
| 1-Year Change | +272.32% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Biodesix at a Glance
As of the Oct 23, 2026 close, Biodesix (BDSX) has a market capitalization of $218.07M. The stock trades at 2.1× sales. Over the trailing twelve months it lost $27.76M on revenue of $102.94M and burned $20.34M of free cash flow. Revenue grew 34.5% year over year.
As of its latest reported balance sheet, it holds $30.00M in cash and securities against $48.43M of debt, a net debt position of $18.43M.
Biodesix does not currently pay a dividend.
The share price is up 272.3% over the past year. At $21.18 (the Oct 23, 2026 close) it sits within its 52-week range of $5.26 to $31.97, above its 200-day moving average of $18.03.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $39.00, 84.1% above the Oct 23, 2026 close.
Frequently Asked Questions About Biodesix
What is the current stock price for BDSX?
As of the Oct 23, 2026 close, BDSX stock trades at $21.18. The 52-week range is $5.26–$31.97, with a day range of $21.11–$23.70.
What is the P/E ratio for BDSX?
The P/E ratio (Price-to-Earnings) for BDSX is shown in the Key Statistics section. This valuation metric helps compare Biodesix, Inc. to industry peers.
Does BDSX pay dividends?
Biodesix does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BDSX?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for BDSX is Buy. The average 12-month price target is $39.00, a 84.1% upside from the Oct 23, 2026 close of $21.18.
What is the market cap of BDSX?
As of the Oct 23, 2026 close, Biodesix's market capitalization is $218.1M, classifying it as a micro-cap company. Biodesix operates in the Healthcare sector within the Diagnostics & Research industry.